Published on 31 Jan 2024 on Simply Wall St. via Yahoo Finance
Institutional investors in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) lost 3.4% last week but...
Key Insights
Given the large stake in the stock by institutions, Amphastar Pharmaceuticals' stock price might be vulnerable to their trading decisionsA total of 7 investors have a majority stake in the company with 50% ownership Recent sales by insiders
A look at the shareholders of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) can tell us which group is most powerful. The group holding the most number of shares in the company, around 68% to be precise, is institutions. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).